**Summary:**
This notice, issued by the Central Drugs Standard Control Organisation (CDSCO), Cosmetic Division, on December 28, 2009, addresses the submission of regulatory documents for the import and registration of cosmetics in India during the COVID-19 pandemic. It acknowledges the difficulties stakeholders face in obtaining notarized, apostilled, and embassy-attested documents (e.g., Power of Attorney, Free Sale Certificate, Manufacturing License) due to the pandemic.
In continuation of previous notices (COSMisc.3120 dated April 20, 2020, and August 19, 2020), the CDSCO has decided to allow applicants to submit self-attested documents along with an undertaking to provide the notarized and apostilled versions with legal signatures within four months or after the normalization of the COVID-19 situation, whichever is earlier. Applications with self-attested documents will be processed, and import registrations may be issued with the condition that the firm submits the required notarized and apostilled documents after normalization.
This notice is applicable to all stakeholders and is available on the CDSCO website. Dr. V.G. Somani, Drugs Controller General, is the issuing authority.
Key Entities Referenced
Central Drugs Standard Control Organisation: A national regulatory body in India responsible for the regulation of pharmaceuticals and medical devices.
COVID 19: The Coronavirus Disease 2019 pandemic, which caused disruptions in document attestation processes.
Drugs and Cosmetics Act, 1940: An act of the Parliament of India that regulates the import, manufacture, distribution and sale of drugs and cosmetics.
Power of Attorney: A legal document authorizing someone to act on another's behalf, mentioned in the context of regulatory submissions.
Manufacturing License: A license required for the manufacture of cosmetics, mentioned in the context of regulatory submissions.
Dr. V.G Somani: The Drugs Controller General of India at the time of the notice.
Ministry of Health and Family Welfare: A government ministry of India responsible for health policy.
Nirman Bhawan, New Delhi: Location of Ministry of Health and Family Welfare
File No. COS/Misc./31/20
Government of India
Directorate General of Health Services
Central Drugs Standard Control Organisation
(Cosmetic Division)
FDA Bhawan, Kotla Road
New Delhi-11 0002
Date:
218 DEC 2009
NOTICE
Subject: Submission of notarized/ apostilled documents for Import and Registration
of cosmetics in view of COVID 19 - regarding.
This office had received representation about difficulties in submission of notary,
apostilled and embassy attestation of regulatory documents such as Power of Attorney. FSC,
Manufacturing License, with legal signatures etc. due to COVID-19 pandemic.
The matter has been examined carefully in view of situation due to COVID-19 outbreak
and in continuation of the Notice number COS/Misc./31/20 dated 20.04.2020 and 19.08 2020
it has been decided that the applicant may submit applications for import registration as per
the provisions of Drugs and Cosmetics Act, 1940 & Rules made thereunder along with such
documents which are self attested and an undertaking that they will submit the notarized/
apostilled documents with legal signatures after obtaining the same from the concerned
authority after normalization of the situation in light of COVID-19 or within four month
whichever is earlier.
Such applications with self attestation, as and when received, will be processed and, if
found satisfactory, import registration may be issued with the condition that the firm shall
submit notarized/ apostilled documents obtaining the same from the concerned authority after
normalization of situation in light of COVID-19.
=
ee
(Dr. V.G Somani)
Drugs Controller General (I)
To .
All Stakeholders through CDSCO web site.
Copy to:
PS to JS(R), Ministry of Health and Family Welfare, Nirman Bhawan, NewDelhi